Pathway Bioventures is an early-stage life sciences fund for next-generation therapeutics, medical device, and diagnostics companies. It backs entrepreneurs on their mission to improve human health with life sciences innovations. self-described.

Pathway Bioventures

Pathway Bioventures | 254 followers on LinkedIn. Early stage funding for revolutionary life sciences companies | Pathway Bioventures is an early-stage life sciences fund for next-generation therapeutics, medical device, and diagnostics companies. We back outstanding entrepreneurs on their mission to improve human health with breakthrough life sciences innovations.

Partner @ Pathway Bioventures | Founder @ Saros Therapeutics

Matt Martin

CEO | ex-VC | Drug developer | Ecosystem builder | Strategic advisor | Board member

Marta New, PhD, MBA

Managing Partner at Pathway Bioventures

Daniel Jacobs

CEO at Afference, Inc.

Jacob Segil

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 7, 2024 1:45 AM	b54044bc
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 7, 2024 1:45 AM	b953d018
crunchbase trigger	general	Nov 7, 2024 1:45 AM	c04eb599
crunchbase profile	general
li profile	general	Nov 7, 2024 1:45 AM	71899dc3
translate crunchbase fundingrounds	general
peers	general	Nov 7, 2024 1:45 AM	9c589a8c
news basic	general	Nov 7, 2024 1:45 AM	1a218e52
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PATH

COM:PATHWAYBIOVENTURES

Pathway Bioventures